Gesynta Pharma

Series-B+
gesynta.se Biotech & Healthcare
Total Funding $28M
Latest Round Undisclosed Series-B+
Last Announced Jul 23, 2025
Investors Undisclosed
Decision Makers 6 Verified

About Gesynta Pharma

Gesynta Pharma is a Swedish pharmaceutical company that develops unique drug candidates with the aim to reduce harmful inflammation and increase blood flow in the body’s microvasculature, thereby providing safe and efficacious treatments for several serious diseases.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website gesynta.se
Domain Registered Date Mar 17, 2017

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Series-B+ announced

    fundraisingfox.com

  2. Capital Raise

    Raised $28,000,000 · Series-B+

    fundraisingfox.com

  3. Milestone

    Website domain registered

    gesynta.se

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Gesynta Pharma.

Funding History

2 Rounds
Series-B+ · Jul 23, 2025
Series-B+ · Jan 24, 2025

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts